Skip to main content
. 2016 Sep 14;255(3):493–502. doi: 10.1007/s00417-016-3489-5

Fig. 5.

Fig. 5

Mean visual acuity in eyes with polypoidal choroidal vasculopathy treated with aflibercept every 2 months following three monthly loading injections. An increase in subretinal/intraretinal fluid was noted in 14 eyes after extending the treatment interval from 1 to 2 months. Patients with recurrent fluid had a significantly worse visual acuity than patients with no recurrence. * indicates a statistically significant difference between groups (P < .05). Error bars indicate quartile values